Public Citizen Health Research Director To Keep Banging Drum On Stronger Benefit-Risk Ratios
Executive Summary
Robert Steinbrook, the 50-year-old health group's third director, plans to stay true to organization’s long-held mission of holding FDA drug approvals to high standards, pushing for stronger evidence of benefit, more attention to safety, and advisory committee votes.